Management of Residual Mass in Germ Cell Tumors After Chemotherapy.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0758-6
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2019 AND VI 21 AND IP 1
Results: 9
1
2
A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0757-7
- By:
- Publication type:
- Article
3
Colon Cancer in Young Adults: Trends and Their Implications.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0756-8
- By:
- Publication type:
- Article
4
On Heartbreak in Oncology.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0755-9
- By:
- Publication type:
- Article
5
Plasma Cell Leukemia: Definition, Presentation, and Treatment.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0754-x
- By:
- Publication type:
- Article
6
Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0753-y
- By:
- Publication type:
- Article
7
HIF Inhibitors: Status of Current Clinical Development.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0752-z
- By:
- Publication type:
- Article
8
Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0751-0
- By:
- Publication type:
- Article
9
Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 1, p. 1, doi. 10.1007/s11912-019-0750-1
- By:
- Publication type:
- Article